Jane Street Group, LLC Penumbra Inc Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.64 - $210.12 $13.9 Million - $17.9 Million	85,200 New	85,200 $16.5 Million
Q1 2022 May 17, 2022	BUY	$187.51 - $283.98 $3.62 Million - $5.48 Million	19,300 Added 120.63%	35,300 $7.84 Million
Q4 2021 Feb 15, 2022	BUY	$238.08 - $288.0 $23,808 - $28,800	100 Added 0.63%	16,000 $4.6 Million
Q3 2021 Nov 16, 2021	SELL	$250.72 - $291.24 $3.08 Million - $3.58 Million	-12,300 Reduced 43.62%	15,900 $4.24 Million
Q2 2021 Aug 16, 2021	SELL	$235.0 - $310.7 $3.24 Million - $4.29 Million	-13,800 Reduced 32.86%	28,200 $7.73 Million
Q1 2021 May 18, 2021	SELL	$175.6 - $291.43 $3.85 Million - $6.38 Million	-21,900 Reduced 34.27%	42,000 $11.4 Million
Q4 2020 Feb 17, 2021	BUY	$174.98 - $272.83 $8.89 Million - $13.9 Million	50,800 Added 387.79%	63,900 $11.2 Million
Q3 2020 Nov 17, 2020	BUY	$185.27 - $238.73 $2.19 Million - $2.82 Million	11,800 Added 907.69%	13,100 $2.55 Million
Q2 2020 Aug 17, 2020	BUY	$153.32 - $191.72 $199,316 - $249,236	1,300 New	1,300 $232,000

374

29.2M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.37B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.